Development of Monoclonal Antibody Therapeutics for Anthrax

炭疽单克隆抗体疗法的开发

• 批准号: 10428336
• 负责人: Virginia G. Johnson
• 金额: $ 144.84万
• 依托单位: EMERGENT PRODUCT DEVELOPMENT GAITHERSBUR
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-01 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10428336
• 关键词: Advanced Development; Animals; Anthrax disease; Area; Bacillus anthracis; Contracts; Development; Support Contracts; Therapeutic; Therapeutic Monoclonal Antibodies; Work; clinical development; falls; preclinical development; therapeutic development

This contract supports the advanced development of a therapeutic for the treatment of anthrax. The scope of work for this contract includes preclinical and clinical development activities that fall into the following areas: IND-enabling activities; manufacturing activities; animal study activities; and BLA-enabling activities.

该合同支持炭疽治疗药物的先进开发。该合同的工作范围包括属于以下领域的临床前和临床开发活动： IND 支持活动；制造活动；动物研究活动；和 BLA 支持活动。